Bide Pharmatech Balance Sheet Health
Financial Health criteria checks 6/6
Bide Pharmatech has a total shareholder equity of CN¥2.0B and total debt of CN¥39.8M, which brings its debt-to-equity ratio to 1.9%. Its total assets and total liabilities are CN¥2.4B and CN¥336.7M respectively. Bide Pharmatech's EBIT is CN¥86.4M making its interest coverage ratio -3. It has cash and short-term investments of CN¥1.3B.
Key information
1.9%
Debt to equity ratio
CN¥39.75m
Debt
Interest coverage ratio | -3x |
Cash | CN¥1.28b |
Equity | CN¥2.05b |
Total liabilities | CN¥336.68m |
Total assets | CN¥2.38b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 688073's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥296.5M).
Long Term Liabilities: 688073's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥40.2M).
Debt to Equity History and Analysis
Debt Level: 688073 has more cash than its total debt.
Reducing Debt: 688073's debt to equity ratio has reduced from 43.3% to 1.9% over the past 5 years.
Debt Coverage: 688073's debt is well covered by operating cash flow (30.8%).
Interest Coverage: 688073 earns more interest than it pays, so coverage of interest payments is not a concern.